ZA200810763B - Imidazolidinone Kv1.5 potassium channel inhibitors - Google Patents

Imidazolidinone Kv1.5 potassium channel inhibitors

Info

Publication number
ZA200810763B
ZA200810763B ZA200810763A ZA200810763A ZA200810763B ZA 200810763 B ZA200810763 B ZA 200810763B ZA 200810763 A ZA200810763 A ZA 200810763A ZA 200810763 A ZA200810763 A ZA 200810763A ZA 200810763 B ZA200810763 B ZA 200810763B
Authority
ZA
South Africa
Prior art keywords
imidazolidinone
potassium channel
channel inhibitors
inhibitors
potassium
Prior art date
Application number
ZA200810763A
Other languages
English (en)
Inventor
Jansuz John Michael
Hodson Stephen Joseph
Bosch Gregory Kent
White Ronald Eugene
Benjamin E Blass
Christopher M Jackson
Neil T Fairweather
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of ZA200810763B publication Critical patent/ZA200810763B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/38—One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200810763A 2006-06-20 2008-12-19 Imidazolidinone Kv1.5 potassium channel inhibitors ZA200810763B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81509106P 2006-06-20 2006-06-20

Publications (1)

Publication Number Publication Date
ZA200810763B true ZA200810763B (en) 2009-09-30

Family

ID=38582320

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200810763A ZA200810763B (en) 2006-06-20 2008-12-19 Imidazolidinone Kv1.5 potassium channel inhibitors

Country Status (20)

Country Link
US (2) US7504517B2 (https=)
EP (1) EP2035392A1 (https=)
JP (1) JP2009541343A (https=)
KR (1) KR20090021223A (https=)
CN (1) CN101573341A (https=)
AR (1) AR061523A1 (https=)
AU (1) AU2007260985A1 (https=)
BR (1) BRPI0713320A2 (https=)
CA (1) CA2655574A1 (https=)
CL (1) CL2007001794A1 (https=)
CO (1) CO6150173A2 (https=)
CR (1) CR10527A (https=)
EC (1) ECSP088994A (https=)
MX (1) MX2008016399A (https=)
NO (1) NO20085252L (https=)
PE (1) PE20080942A1 (https=)
RU (1) RU2008150465A (https=)
TW (1) TW200815363A (https=)
WO (1) WO2007149874A1 (https=)
ZA (1) ZA200810763B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2008150465A (ru) * 2006-06-20 2010-07-27 Вайет (Us) Ингибиторы калиевых каналов подтипа kv1.5
RU2373934C1 (ru) * 2008-03-19 2009-11-27 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Применение производных глутаровой кислоты или их фармацевтически приемлемых солей в качестве противоаритмических средств
CN101544580B (zh) * 2009-04-28 2019-03-15 大连凯飞精细化工有限公司 R-alpha-氨基-4-甲氧基苯乙酰胺的合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4099009A (en) * 1977-04-11 1978-07-04 Morton-Norwick Products, Inc. 1-(4-chlorophenyl)-3-(1-ureido)-2-imidazolidinone
SK94393A3 (en) 1992-09-11 1994-08-10 Thomae Gmbh Dr K Cyclic derivatives of urea, process for their production and their pharmaceutical agents with the content of those
DE4332168A1 (de) 1993-02-22 1995-03-23 Thomae Gmbh Dr K Cyclische Derivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
HUP9901024A2 (hu) 1996-01-26 1999-09-28 Vertex Pharmaceuticals Incorporated Telített azolok oxoszármazékai, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
EP0891353A4 (en) 1996-04-03 2001-08-08 Merck & Co Inc FARNESYL PROTEIN TRANSFERASE INHIBITORS
US7129359B2 (en) 2002-07-09 2006-10-31 National Health Research Institutes Imidazolidinone compounds
US7544812B2 (en) 2001-11-30 2009-06-09 Eli Lilly And Company Peroxisome proliferator activated receptor agonists
US7189856B2 (en) 2001-12-28 2007-03-13 Gideon Shapiro Non-peptide somatostatin receptor ligands
AU2003302027A1 (en) 2002-11-21 2004-06-15 Vicore Pharma Ab New tricyclic angiotensin ii agonists
JP2004262903A (ja) 2003-03-04 2004-09-24 Japan Science & Technology Agency アジリジン類の製造方法
US7259174B2 (en) 2004-05-25 2007-08-21 National Health Research Institutes Imidazolidinone compounds
TW200624429A (en) 2004-09-07 2006-07-16 Glaxo Group Ltd Novel cysteine protease inhibitors
KR100677149B1 (ko) 2004-11-12 2007-02-02 삼성전자주식회사 잉크 조성물
RU2008150465A (ru) * 2006-06-20 2010-07-27 Вайет (Us) Ингибиторы калиевых каналов подтипа kv1.5

Also Published As

Publication number Publication date
NO20085252L (no) 2009-01-13
BRPI0713320A2 (pt) 2012-02-07
US7504517B2 (en) 2009-03-17
WO2007149874A8 (en) 2008-03-20
CR10527A (es) 2009-02-19
AU2007260985A1 (en) 2007-12-27
CO6150173A2 (es) 2010-04-20
KR20090021223A (ko) 2009-02-27
TW200815363A (en) 2008-04-01
JP2009541343A (ja) 2009-11-26
CA2655574A1 (en) 2007-12-27
EP2035392A1 (en) 2009-03-18
MX2008016399A (es) 2009-02-03
WO2007149874A1 (en) 2007-12-27
CL2007001794A1 (es) 2008-01-18
US20090069342A1 (en) 2009-03-12
US20070299120A1 (en) 2007-12-27
AR061523A1 (es) 2008-09-03
CN101573341A (zh) 2009-11-04
ECSP088994A (es) 2009-01-30
PE20080942A1 (es) 2008-09-03
US7803827B2 (en) 2010-09-28
RU2008150465A (ru) 2010-07-27

Similar Documents

Publication Publication Date Title
IL196989A0 (en) Cyclic ii-?? hydroxysteroid dehydrogenase type 1 inhibitors
AP2402A (en) Amine derivatives.
IL185185A0 (en) Azolylacylguanidines as ??-secretase inhibitors
PT2094263E (pt) Derivados da 2-adamantil-butiramida como inibidores seletivos da 11-beta-hsd1
SI2037922T1 (sl) Prolil hidrolazni inhibitorji
IL179398A0 (en) Dpp-ib inhibitors
IL195279A0 (en) 1,5-diphenylpyrazoles ii as hsp90 inhibitors
ZA200610142B (en) Furanopyrimidine compounds effective as potassium channel inhibitors
IL198462A0 (en) Diazepane-acetamide derivatives as selective 11??-hsd1 inhibitors
IL192635A0 (en) Cis-4,5-biaryl-2-heterocyclic-imidazolines as mdm2 inhibitors
IL190081A0 (en) Nnrt inhibitors
ZA201005087B (en) 4-imidazolidinones as kv1.5 potassium channel inhibitors
PL1912972T3 (pl) Podstawione związki imidazolowe jako inhibitory KSP
TWI365621B (en) Channel estimation
EP2038304A4 (en) BST2 INHIBITORS
TWM299071U (en) Hole saw
GB0819432D0 (en) Compound, composition and use
GB0421355D0 (en) Inhibitors
ZA200810763B (en) Imidazolidinone Kv1.5 potassium channel inhibitors
ZA201005086B (en) 4-imidazolidinones as kv1.5 potassium channel inhibitors
EP1776355A4 (en) POTASSIUM CHANNEL INHIBITORS
EP2056852A4 (en) BMP-7 VARIANTS COMPOSITIONS, METHODS AND USES
GB0421356D0 (en) Inhibitors
GB0622702D0 (en) Selective glycosidase inhibitors
PT2010509E (pt) Derivados de 3,4-diamino-3-ciclobuteno-1,2-diona como agentes de dilatação do canal de potássio